Profound Medical (PROF) Competitors $5.51 -0.07 (-1.25%) Closing price 08/6/2025 03:59 PM EasternExtended Trading$5.44 -0.08 (-1.36%) As of 08/6/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PROF vs. BBNX, AXGN, AVNS, KIDS, CBLL, BVS, SMLR, ZIMV, BFLY, and DCTHShould you be buying Profound Medical stock or one of its competitors? The main competitors of Profound Medical include Beta Bionics (BBNX), AxoGen (AXGN), Avanos Medical (AVNS), OrthoPediatrics (KIDS), CeriBell (CBLL), Bioventus (BVS), Semler Scientific (SMLR), ZimVie (ZIMV), Butterfly Network (BFLY), and Delcath Systems (DCTH). These companies are all part of the "medical equipment" industry. Profound Medical vs. Its Competitors Beta Bionics AxoGen Avanos Medical OrthoPediatrics CeriBell Bioventus Semler Scientific ZimVie Butterfly Network Delcath Systems Beta Bionics (NASDAQ:BBNX) and Profound Medical (NASDAQ:PROF) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, risk, institutional ownership, earnings, analyst recommendations, valuation and dividends. Does the media refer more to BBNX or PROF? In the previous week, Beta Bionics had 17 more articles in the media than Profound Medical. MarketBeat recorded 17 mentions for Beta Bionics and 0 mentions for Profound Medical. Beta Bionics' average media sentiment score of 0.37 beat Profound Medical's score of 0.00 indicating that Beta Bionics is being referred to more favorably in the media. Company Overall Sentiment Beta Bionics Neutral Profound Medical Neutral Is BBNX or PROF more profitable? Beta Bionics has a net margin of 0.00% compared to Profound Medical's net margin of -269.35%. Beta Bionics' return on equity of 0.00% beat Profound Medical's return on equity.Company Net Margins Return on Equity Return on Assets Beta BionicsN/A N/A N/A Profound Medical -269.35%-70.41%-57.22% Which has higher earnings and valuation, BBNX or PROF? Profound Medical has lower revenue, but higher earnings than Beta Bionics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBeta Bionics$65.12M10.15-$54.76MN/AN/AProfound Medical$10.68M15.50-$27.82M-$1.22-4.52 Do analysts prefer BBNX or PROF? Beta Bionics currently has a consensus price target of $22.56, indicating a potential upside of 48.39%. Profound Medical has a consensus price target of $11.00, indicating a potential upside of 99.64%. Given Profound Medical's stronger consensus rating and higher possible upside, analysts plainly believe Profound Medical is more favorable than Beta Bionics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Beta Bionics 0 Sell rating(s) 4 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 2.75Profound Medical 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders & institutionals believe in BBNX or PROF? 47.9% of Profound Medical shares are held by institutional investors. 1.5% of Profound Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. SummaryBeta Bionics beats Profound Medical on 8 of the 14 factors compared between the two stocks. Get Profound Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for PROF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PROF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PROF vs. The Competition Export to ExcelMetricProfound MedicalMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$167.70M$2.52B$5.57B$9.47BDividend YieldN/A1.77%4.31%4.13%P/E Ratio-4.5219.5129.3723.99Price / Sales15.50691.00444.2496.60Price / CashN/A162.3535.8458.51Price / Book2.745.208.085.58Net Income-$27.82M$31.61M$3.26B$265.35M7 Day Performance-0.72%0.90%0.46%-0.07%1 Month Performance-9.52%6.97%4.84%1.76%1 Year Performance-42.60%6.15%30.29%25.39% Profound Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PROFProfound Medical1.8255 of 5 stars$5.51-1.3%$11.00+99.6%-41.7%$167.70M$10.68M-4.52150Upcoming EarningsBBNXBeta Bionics2.6889 of 5 stars$13.99-5.7%$23.44+67.6%N/A$643.41M$65.12M0.00294AXGNAxoGen2.2907 of 5 stars$12.99-2.8%$24.50+88.6%+75.6%$608.92M$187.34M-86.59450High Trading VolumeAVNSAvanos Medical1.7184 of 5 stars$12.02+0.1%N/A-55.1%$555.39M$687.80M-1.442,227Trending NewsEarnings ReportKIDSOrthoPediatrics3.8928 of 5 stars$22.39-1.6%$35.83+60.0%-34.3%$552.52M$204.73M-12.79200Trending NewsEarnings ReportAnalyst ForecastCBLLCeriBell2.8469 of 5 stars$14.96-1.1%$32.14+114.9%N/A$546.84M$65.44M0.00N/AEarnings ReportBVSBioventus1.8892 of 5 stars$6.53-0.6%N/AN/A$539.69M$573.28M-13.601,200News CoverageNegative NewsEarnings ReportGap UpSMLRSemler Scientific3.4001 of 5 stars$39.25+3.1%$82.00+108.9%+29.6%$525.05M$49.23M-15.04120News CoverageEarnings ReportAnalyst ForecastGap UpZIMVZimVie0.912 of 5 stars$18.82+0.5%$17.00-9.7%+9.7%$521.30M$449.75M-26.511,770BFLYButterfly Network2.382 of 5 stars$1.93-2.0%$3.50+81.3%+38.9%$487.16M$82.06M-6.66460Earnings ReportAnalyst ForecastGap UpDCTHDelcath Systems3.0186 of 5 stars$11.41flat$24.00+110.3%+34.5%$397.37M$37.21M-22.8260News CoverageGap Up Related Companies and Tools Related Companies BBNX Competitors AXGN Competitors AVNS Competitors KIDS Competitors CBLL Competitors BVS Competitors SMLR Competitors ZIMV Competitors BFLY Competitors DCTH Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PROF) was last updated on 8/7/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredCrypto bros: Meet your replacementLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredSell these "safe" blue chips immediatelyInvesting Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | SponsoredEx-Hedge Fund Manager Uncovers $100 Trillion Land ShiftTrump's Radical New Plan Could Enrich Thousands This isn't a campaign stunt. It's a $100 trillion move to u...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Profound Medical Please log in to your account or sign up in order to add this asset to your watchlist. Share Profound Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
